LSM8 is a core component of the heptameric LSM2-8 complex, which binds to the 3'-terminal U-tract of U6 snRNA and plays a critical role in spliceosome assembly and pre-mRNA splicing. The protein functions within the U4/U6-U5 tri-snRNP complex and the precatalytic spliceosome, facilitating the formation of functional splicing machinery. Beyond its nuclear role in splicing, LSM8 regulates the subcellular localization of other LSM proteins; depletion of nuclear LSM8 causes relocalization of LSM2-7 proteins to the cytoplasm, which increases the number of cytoplasmic processing bodies involved in mRNA degradation 1. LSM8 has been identified as a candidate modifier gene associated with asbestos-related disease latency in both mouse models and human mesothelioma datasets 2, and genetic variants near LSM8 show suggestive association with thyroid antibody levels in Hashimoto's thyroiditis patients 3. A genetic variant in the LSM8 region (rs39745/CTTNBP2-LSM8) was identified as recessively associated with high triglycerides in an Arab population 4. The gene's expression is regulated by hypoxia and may contribute to tissue-specific vulnerability in retinal degeneration 5. These findings suggest LSM8 functions in both fundamental RNA processing and complex disease susceptibility.